PDCD1 and cancer: In addition to depending on TCR activation, the extent and duration of PD-1 expression by T cells is regulated via IFNAR signaling, which means that IFNAR signaling weakens T cell responses in the context of continuous T cell activation (e.g., during chronic infection or cancer) [33].